287 related articles for article (PubMed ID: 30936106)
21. Prevalence and Molecular Characteristics of Carbapenemase-Producing Enterobacteriaceae From Five Hospitals in Korea.
Jeong SH; Kim HS; Kim JS; Shin DH; Kim HS; Park MJ; Shin S; Hong JS; Lee SS; Song W
Ann Lab Med; 2016 Nov; 36(6):529-35. PubMed ID: 27578505
[TBL] [Abstract][Full Text] [Related]
22. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden.
Samuelsen Ø; Naseer U; Tofteland S; Skutlaberg DH; Onken A; Hjetland R; Sundsfjord A; Giske CG
J Antimicrob Chemother; 2009 Apr; 63(4):654-8. PubMed ID: 19218573
[TBL] [Abstract][Full Text] [Related]
23. First Report of Klebsiella oxytoca Strain Simultaneously Producing NDM-1, IMP-4, and KPC-2 Carbapenemases.
Wang J; Yuan M; Chen H; Chen X; Jia Y; Zhu X; Bai L; Bai X; Fanning S; Lu J; Li J
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674063
[TBL] [Abstract][Full Text] [Related]
24. Surveillance and molecular epidemiology of Klebsiella pneumoniae isolates that produce carbapenemases: first report of OXA-48-like enzymes in North America.
Lascols C; Peirano G; Hackel M; Laupland KB; Pitout JD
Antimicrob Agents Chemother; 2013 Jan; 57(1):130-6. PubMed ID: 23070171
[TBL] [Abstract][Full Text] [Related]
25. Dissemination of clinical isolates of Klebsiella oxytoca harboring CMY-31, VIM-1, and a New OXY-2-type variant in the community.
Tsakris A; Poulou A; Markou F; Pitiriga V; Piperaki ET; Kristo I; Pournaras S
Antimicrob Agents Chemother; 2011 Jul; 55(7):3164-8. PubMed ID: 21555768
[TBL] [Abstract][Full Text] [Related]
26. Characterization of Carbapenemase-Producing Enterobacteriaceae from Patients in Amman, Jordan.
Aqel AA; Findlay J; Al-Maayteh M; Al-Kaabneh A; Hopkins KL; Alzoubi H; Masalha I; Turton J; Woodford N; Ellington MJ
Microb Drug Resist; 2018 Oct; 24(8):1121-1127. PubMed ID: 29653473
[TBL] [Abstract][Full Text] [Related]
27. VIM/IMP carbapenemase-producing Enterobacteriaceae in Poland: epidemic Enterobacter hormaechei and Klebsiella oxytoca lineages.
Izdebski R; Baraniak A; Zabicka D; Sekowska A; Gospodarek-Komkowska E; Hryniewicz W; Gniadkowski M
J Antimicrob Chemother; 2018 Oct; 73(10):2675-2681. PubMed ID: 29986025
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and clonal relatedness of NDM and OXA-48-producing
Remya P; Shanthi M; Sekar U
J Lab Physicians; 2019; 11(4):312-316. PubMed ID: 31929696
[TBL] [Abstract][Full Text] [Related]
29. Multicentre investigation of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Bulgarian hospitals - Interregional spread of ST11 NDM-1-producing K. pneumoniae.
Markovska R; Stoeva T; Boyanova L; Stankova P; Schneider I; Keuleyan E; Mihova K; Murdjeva M; Sredkova M; Lesseva M; Nedelcheva G; Petrova A; Ivanova D; Lazarova G; Kaneva R; Mitov I
Infect Genet Evol; 2019 Apr; 69():61-67. PubMed ID: 30654179
[TBL] [Abstract][Full Text] [Related]
30. Prospective multicenter study of carbapenemase-producing Enterobacteriaceae from 83 hospitals in Spain reveals high in vitro susceptibility to colistin and meropenem.
Oteo J; Ortega A; Bartolomé R; Bou G; Conejo C; Fernández-Martínez M; González-López JJ; Martínez-García L; Martínez-Martínez L; Merino M; Miró E; Mora M; Navarro F; Oliver A; Pascual Á; Rodríguez-Baño J; Ruiz-Carrascoso G; Ruiz-Garbajosa P; Zamorano L; Bautista V; Pérez-Vázquez M; Campos J;
Antimicrob Agents Chemother; 2015; 59(6):3406-12. PubMed ID: 25824224
[TBL] [Abstract][Full Text] [Related]
31. A Two-Year Surveillance in Five Colombian Tertiary Care Hospitals Reveals High Frequency of Non-CG258 Clones of Carbapenem-Resistant Klebsiella pneumoniae with Distinct Clinical Characteristics.
Ocampo AM; Chen L; Cienfuegos AV; Roncancio G; Chavda KD; Kreiswirth BN; Jiménez JN
Antimicrob Agents Chemother; 2016 Jan; 60(1):332-42. PubMed ID: 26503660
[TBL] [Abstract][Full Text] [Related]
32. A ten-year surveillance study of carbapenemase-producing Klebsiella pneumoniae in a tertiary care Greek university hospital: predominance of KPC- over VIM- or NDM-producing isolates.
Spyropoulou A; Papadimitriou-Olivgeris M; Bartzavali C; Vamvakopoulou S; Marangos M; Spiliopoulou I; Anastassiou ED; Christofidou M
J Med Microbiol; 2016 Mar; 65(3):240-246. PubMed ID: 26698320
[TBL] [Abstract][Full Text] [Related]
33. Molecular epidemiology of carbapenemase-producing Escherichia coli and the prevalence of ST131 subclone H30 in Shanghai, China.
Zhang F; Zhu D; Xie L; Guo X; Ni Y; Sun J
Eur J Clin Microbiol Infect Dis; 2015 Jun; 34(6):1263-9. PubMed ID: 25759112
[TBL] [Abstract][Full Text] [Related]
34. Characterization of Piperacillin/Tazobactam-Resistant Klebsiella oxytoca Recovered from a Nosocomial Outbreak.
Fujita A; Kimura K; Yokoyama S; Jin W; Wachino J; Yamada K; Suematsu H; Yamagishi Y; Mikamo H; Arakawa Y
PLoS One; 2015; 10(11):e0142366. PubMed ID: 26539828
[TBL] [Abstract][Full Text] [Related]
35. Emergence of two novel sequence types (3366 and 3367) NDM-1- and OXA-48-co-producing K. pneumoniae in Italy.
Gona F; Bongiorno D; Aprile A; Corazza E; Pasqua B; Scuderi MG; Chiacchiaretta M; Cirillo DM; Stefani S; Mezzatesta ML
Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1687-1691. PubMed ID: 31165962
[TBL] [Abstract][Full Text] [Related]
36. Characterization of OXA-48-producing Klebsiella oxytoca isolates from a hospital outbreak in Tunisia.
Guzmán-Puche J; Jenayeh R; Pérez-Vázquez M; Manuel-Causse ; Asma F; Jalel B; Oteo-Iglesias J; Martínez-Martínez L
J Glob Antimicrob Resist; 2021 Mar; 24():306-310. PubMed ID: 33545421
[TBL] [Abstract][Full Text] [Related]
37. First Description of KPC-2-Producing Escherichia coli and ST15 OXA-48-Positive Klebsiella pneumoniae in Tunisia.
Ben Tanfous F; Alonso CA; Achour W; Ruiz-Ripa L; Torres C; Ben Hassen A
Microb Drug Resist; 2017 Apr; 23(3):365-375. PubMed ID: 27754776
[TBL] [Abstract][Full Text] [Related]
38. CARB-ES-19 Multicenter Study of Carbapenemase-Producing
Cañada-García JE; Moure Z; Sola-Campoy PJ; Delgado-Valverde M; Cano ME; Gijón D; González M; Gracia-Ahufinger I; Larrosa N; Mulet X; Pitart C; Rivera A; Bou G; Calvo J; Cantón R; González-López JJ; Martínez-Martínez L; Navarro F; Oliver A; Palacios-Baena ZR; Pascual Á; Ruiz-Carrascoso G; Vila J; Aracil B; Pérez-Vázquez M; Oteo-Iglesias J;
Front Microbiol; 2022; 13():918362. PubMed ID: 35847090
[TBL] [Abstract][Full Text] [Related]
39. Emergence of a multiresistant KPC-3 and VIM-1 carbapenemase-producing Escherichia coli strain in Spain.
Porres-Osante N; Azcona-Gutiérrez JM; Rojo-Bezares B; Undabeitia E; Torres C; Sáenz Y
J Antimicrob Chemother; 2014 Jul; 69(7):1792-5. PubMed ID: 24583362
[TBL] [Abstract][Full Text] [Related]
40. KPC-Producing Klebsiella pneumoniae Isolates in Croatia: A Nationwide Survey.
Jelic M; Butic I; Plecko V; Cipris I; Jajic I; Bejuk D; Koscak I; Marinkovic S; Pal MP; Andrasevic AT
Microb Drug Resist; 2016 Dec; 22(8):662-667. PubMed ID: 26709956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
